Microdosing Tirzepatide
- Dual GLP-1 + GIP signaling at lower, capped doses designed to support long-term metabolic health and resilience—promoting steady energy, cognitive clarity, and metabolic regulation while minimizing side effects
- Ideal for patients seeking sustainable, longevity-focused benefits over time (weight loss may occur, but isn’t the primary aim)
- Medication shipped every 12 weeks
- Ongoing Provider Care & Support


















.png)
